Navigation Links
Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
Date:5/7/2008

K for the year ended December 31, 2007.


'/>"/>
SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
2. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
3. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
4. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
5. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
6. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
7. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
8. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
9. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
10. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
11. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/8/2008)... BOSTON, May 8 /- The Cancer Res... the nation,s top cancer centers, is asking,303 mi...r by donating $1 to,cancer research efforts this M...dubbed the "Infinite Power of One(TM)" has two key...atters into their own hands by,joining together to...
(Date:5/8/2008)... TAMPA, Fla., May 8 /-...harmaceutical company, today announced results fro...(morphine sulfate,extended-release with sequestere...clinically relevant features addressing abuse liab...ofile. The Phase I and II,studies, presented at th...
(Date:5/8/2008)... NEW HAVEN, Conn., May 8 /PRNewswire-FirstCal...today announced the start of an investigator-spons...cer agent Cloretazine(R),(VNP40101M) in combinatio...sly untreated acute myelogenous leukemia (AML) and...ial is being conducted under the,direction of Elle...
(Date:5/8/2008)... - Memorial Sloan-Kettering Cancer Center Inves...CA-Negative Ovarian Cancer Patients -, BRISBANE, ... today,announced the expansion of Phase 2 clinical...ovarian cancer. This is the third major clinical t...t 6 months, expanding on,on-going trials in breast...
Breaking Medicine Technology:World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 2World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 3World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 4World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2Novel Cooling Therapy May Have Aided Injured Football Player 1209 1Novel Cooling Therapy May Have Aided Injured Football Player 1209 2Novel Cooling Therapy May Have Aided Injured Football Player 1209 3Novel Cooling Therapy May Have Aided Injured Football Player 1209 4Leaderless movement proves illusive 380 1Leaderless movement proves illusive 380 2Joint Juice Launches New Ready to Drink Glucosamine 26 Vitamin Enhanced Dietary Supplement Water Nationwide 1207 1Joint Juice Launches New Ready to Drink Glucosamine 26 Vitamin Enhanced Dietary Supplement Water Nationwide 1207 2Frances Decker Named Mid Atlantic Region Sales Executive for AllOne Health Management Solutions 1205 1Frances Decker Named Mid Atlantic Region Sales Executive for AllOne Health Management Solutions 1205 2
... significant additional protection against,infecti...cervical,cancer candidate vaccine, PHILADELPHIA, J...m an interim analysis of a Phase III study show th...r candidate vaccine,provides up to 100 percent pr...sed by the most common types of human papillomavir...
...Synagis Decreases Incidence of Recurrent Wheeze by...Md., June 29, 2007,/PRNewswire-FirstCall/ -- Abbot...tudy, published in the July issue of Journal of,Pe...palivizumab),may reduce recurrent wheezing in prem...study showed that premature infants without,chroni...
Other Medicine Technology:Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 2Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 3Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 4Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 5Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 6Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix,Provides Excellent Protection Against Lesions Caused by Most Common,Cancer-Causing Virus Types 7New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 2New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 3New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 4New Study in Journal of Pediatrics Suggests Synagis (Palivizumab),May Reduce Subsequent Recurrent Wheezing in Preterm Infants 5
(Date:5/9/2008)...rst Medication Indicated for Maintenance Treatment...all/ -- Eli Lilly and Company,(NYSE: LLY ) announ...inistration (FDA) has approved Strattera(R) (atomo...-Deficit/Hyperactivity Disorder (ADHD) in,children...hrine reuptake,inhibitor, is the first FDA-approve...
(Date:5/9/2008)...NGELES, May 9 /PRNewswire/ -- Los Angeles based Op...n Asia to assess the needs of what is now,an estim...ne which,destroyed or devastated wide swaths of My...ormerly the capital Rangoon) and throughout its va... of over 120 miles per hour and,struck communities...
(Date:5/9/2008)...tion for Iraq and Afghanistan Veterans Gather in V...eterans Service Organizations,, CHANTILLY, Va....raq,enters its fifth year and the U.S. death toll ...he 30,000 mark, a diverse coalition of military,an...have organized to help,bereaved families and wound...
(Date:5/9/2008)...ual demands reap mental benefits regardless of age...ay 9 (HealthDay News) -- Having an intellectually ... result in better cognitive abilities during retir... or age, a Duke University Medical Center study su...work longer than previous generations, so we sough...
Breaking Medicine News(10 mins):Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 3Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 5Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 6Health News:Los Angeles Based Operation USA Appeals for Funds to Aid in Myanmar (Burmese) Cyclone Disaster (Updated) 2Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 2Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 3Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 4Health News:Demanding Jobs May Pay Cognitive Dividends in Retirement 2
... by which an breastfeeding women who is also overw...at the overweight women who are breastfeeding and ...ir target by decreasing the amount of sweetened dr... in their diet. They have also recommended that sh...
...ok had as of yesterday cleared the three people wh... the deadly H5N1 virus// from the bird flu watch-l...om common flu. Confirming that the three patients... bird flu were suffering from influenza, Dr Prat B...
...Vermont say that drinking cherry juice may be the ... number of antioxidant// and anti-inflammatory com... conditions. In one study The British Journal of ... men and women who ate 45 cherries per day had low...
...new education bill in the state that allows privat... non-resident Indian (NRI) students//. Lok Sabha m...f Daily News newspaper, described the new bill as ...ght it. He was in Bahrain to attend a memorial me...
Other Medicine News:Health News:Diet & Exercise regime Not Harmful For Overweight, Lactating Mothers Or their Infants 2
...hermo Labsystems was designed specifically to comb...dvanced features such as the new fast dial system ...help to define this as a new leader in single chan... offers a custom fit for different hand sizes. The...
Super High Density, multi-frequency, phased array burr hole transducer. Excellent for taking biopsy samples and shunt placements.
Super High Density, multi-frequency, linear flexible laparoscopic transducer. ALOKA was the first company to introduce a flexible laparoscopic ultrasound transducer and, as a result, changed surgical
...lternative to the UST-995-7.5 for those surgeons w...n relation to the position of the transducer in th...frequency "T shaped convex intraoperative transduc...your index and middle fingers so that you can palp...
Medicine Products: